Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1999
12/29/1999WO1999067388A1 Antisense oligonucleotide inhibiting the expression of il-10 protein
12/29/1999WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof
12/29/1999WO1999067266A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067265A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067264A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067263A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999WO1999067262A1 Adenosine derivatives
12/29/1999WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
12/29/1999WO1999067215A1 Amidino and guanidino azetidinone tryptase inhibitors
12/29/1999WO1999067208A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
12/29/1999WO1999067201A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999WO1999066948A2 Use of a dipeptide for stimulating repair processes
12/29/1999WO1999066947A1 Adjuvant therapy
12/29/1999WO1999066925A1 Protease inhibitors
12/29/1999WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999WO1999057320B1 Antisense modulation of cd40 expression
12/29/1999WO1999055830A3 Process for synthesizing cox-2 inhibitors
12/29/1999WO1999051626A3 Template associated npy y2-receptor agonists
12/29/1999EP0966525A1 Method of using tetracycline compounds for inhibition of nitric oxide production
12/29/1999EP0966465A1 Inhibitors of impdh enzyme
12/29/1999EP0966447A1 Small molecules useful in the treatment of inflammatory disease
12/29/1999EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
12/29/1999EP0966439A1 Certain cyclic thio substituted acylaminoacid amide derivatives
12/29/1999EP0966437A1 5-aroylnaphthalene derivatives
12/29/1999EP0966436A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/29/1999EP0966430A1 Anti-inflammatory compounds
12/29/1999EP0966427A1 Preparation of acid amides and metallisation of compounds
12/29/1999EP0966424A1 Aminobenzophenones as inhibitors of interleukin and tnf
12/29/1999EP0966295A1 Calcareous material
12/29/1999EP0966269A1 Immediate release drug delivery forms
12/29/1999EP0966245A2 Antimicrobial cosmetic compositions
12/29/1999EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
12/29/1999CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels
12/29/1999CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
12/29/1999CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999CN1239895A Radiopharmaceuticals for imaging infection and inflammation
12/29/1999CN1239892A Use of equilenin as antioxidant
12/29/1999CN1239891A Use of 17 '-dihydroequilenin as an antioxidant
12/29/1999CN1239890A 17 'alpha'-dihydroequilenin for use as medical antioxidant
12/29/1999CN1239660A Slow-released analgesic suppository and its preparation process
12/29/1999CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them
12/29/1999CN1047776C Pharmacologically active pyridine derivatives and process for the preparation thereof
12/29/1999CN1047775C N-piperidino 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-formyl amide, its preparation and drug composition
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2336003A1 Amidino and guanidino azetidinone tryptase inhibitors
12/29/1999CA2335876A1 Protease inhibitors
12/29/1999CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999CA2335809A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999CA2335758A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
12/29/1999CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999CA2335373A1 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxyphenylsulfanylarylacetic acids
12/29/1999CA2333750A1 Adjuvant therapy
12/28/1999US6008365 Adrenoreceptor agonists and dopamine da2-receptor agonists, useful in the treatment of obstructive airway diseases
12/28/1999US6008357 1 -azabicyclo(2.2.2)octan-3-amine, (2-diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methy l) is reacted with 1r-(-)-10-camphorsulfonic acid to obtain camphorsulfonic acid salt
12/28/1999US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia
12/28/1999US6008247 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
12/28/1999US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators
12/28/1999US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain
12/28/1999US6008196 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/28/1999US6007821 Immunosuppression; organ transplants, insulin dependent diabetes
12/28/1999CA1340866C Human c3b/c4b receptor (cr1)
12/24/1999CA2241647A1 Transitional metal complexes of non steroidal anti-inflammatory drugs
12/23/1999WO1999066065A2 Proteasomal activity
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066038A1 Angiostatin-binding protein
12/23/1999WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065933A1 Novel cyclosporins
12/23/1999WO1999065916A1 Thienodipyridine derivatives, production and use thereof
12/23/1999WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065478A1 Therapeutic compositions and methods of use
12/23/1999WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999051213A3 The use of polyamines in the treatment of dermatological symptoms
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335184A1 Cyclic somatostatin analogs
12/23/1999CA2335106A1 Thienodipyridine derivatives, production and use thereof
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2332325A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999CA2330228A1 Angiostatin-binding protein
12/23/1999CA2330210A1 Proteasomal activity
12/22/1999EP0964867A2 Tachykinin antagonists
12/22/1999EP0964856A1 Bicyclic amino acids
12/22/1999EP0964851A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion
12/22/1999EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999EP0964677A1 Sustained analgesia achieved with buprenorphine
12/22/1999EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
1 ... 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 ... 1272